Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis

被引:19
作者
Li, Jiaqi [1 ]
Li, Yingxue [1 ]
Zou, Yaowei [1 ]
Chen, Yaode [2 ]
He, Lizhen [2 ]
Wang, Ying [3 ]
Zhou, Jingxuan [3 ]
Xiao, Fangqi [3 ]
Niu, Hongxin [3 ]
Lu, Lingli [2 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Div Nephrol, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Gen Practice, Guangzhou, Peoples R China
[3] Southern Med Univ, Zhujiang Hosp, Gen Practice & Special Med Serv Ctr, Guangzhou, Peoples R China
关键词
Systemic inflammatory response index; microinflammation; peritoneal dialysis; all-cause mortality; cardiovascular disease; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; LYMPHOCYTE RATIO; KIDNEY-DISEASE; PREDICTS; RISK;
D O I
10.1080/0886022X.2022.2100262
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The systemic inflammatory response index (SIRI), a novel inflammation maker, has proven to be associated with prognostic outcomes in various diseases. However, few studies have been conducted assessing how SIRI may influence outcomes of patients on peritoneal dialysis (PD). Herein, we assessed the predictive value of SIRI on mortality all-cause mortality, including cardiovascular disease (CVD) in PD patients. Methods A total of 646 PD patients were enrolled in this study. PD patients received regular PD treatments at the Zhujiang Hospital from 1 January 2011 to 31 December 2018. SIRI values could be computed as follows: neutrophil count x monocyte count/lymphocyte count. Patients were divided into two groups according to the median level of SIRI. Cox regression analysis and Kaplan-Meier methods were applied to analyze the relationship between SIRI and mortality outcomes in PD patients. Results During the median 31-month follow-up period, 97 (15.0%) PD patients died from all-causes, and 47 (49.0%) died of CVD. Kaplan-Meier analyses revealed that a high SIRI corresponded to the high mortality of all-cause deaths, including CVD (both p < 0.001) in patients on PD. After adjusting for potential confounders, the higher SIRI level was significantly associated with an increased all-cause mortality (HR: 2.007, 95% CI: 1.304-3.088, p = 0.002) and cardiovascular mortality (HR: 2.847, 95% CI: 1.445-5.608, p = 0.002). Conclusions SIRI was a promising predictor of mortality in PD patients, with a higher SIRI corresponding to increased risk of mortality.
引用
收藏
页码:1227 / 1235
页数:9
相关论文
共 40 条
  • [21] Diabetes Mellitus and Inflammation
    Lontchi-Yimagou, Eric
    Sobngwi, Eugene
    Matsha, Tandi E.
    Kengne, Andre Pascal
    [J]. CURRENT DIABETES REPORTS, 2013, 13 (03) : 435 - 444
  • [22] The Current State of Peritoneal Dialysis
    Mehrotra, Rajnish
    Devuyst, Olivier
    Davies, Simon J.
    Johnson, David W.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (11): : 3238 - 3252
  • [23] Normal white blood cell counts predict long-term mortality of hemodialysis patients
    Mitsopoulos, Efstathios
    Lysitska, Aikaterini
    Zanos, Stavros
    Mplatsa, Aikaterini
    Alexandrou, Maria-Eleni
    Kevrekidou, Sofia
    Stroppou, Persia
    Zazopoulou, Ourania
    Kalliara, Theodora-Anastasia
    Voudouri, Anastasia
    Pateinakis, Panagiotis
    Manou, Eleni
    Kyriklidou, Parthena
    Papadopoulou, Dorothea
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (04) : 783 - 790
  • [24] ESRD-induced dyslipidemiaShould management of lipid disorders differ in dialysis patients?
    Moradi, Hamid
    Streja, Elani
    Vaziri, Nosratola D.
    [J]. SEMINARS IN DIALYSIS, 2018, 31 (04) : 398 - 405
  • [25] Attitudes to and experiences with body weight control and changes in body weight in relation to all-cause mortality in the general population
    Morgen, Camilla S.
    Angquist, Larsa
    Appleyard, Merete
    Schnohr, Peter
    Jensen, Gorm B.
    Sorensen, Thorkild I. A.
    [J]. PLOS ONE, 2019, 14 (08):
  • [26] A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer
    Pacheco-Barcia, Vilma
    Mondejar Solis, Rebeca
    France, Talya
    Asselah, Jamil
    Donnay, Olga
    Zogopoulos, George
    Bouganim, Nathaniel
    Guo, Katie
    Rogado, Jacobo
    Martin, Elena
    Alcindor, Thierry
    Colomer, Ramon
    [J]. PANCREATOLOGY, 2020, 20 (02) : 254 - 264
  • [27] US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States
    Saran, Rajiv
    Robinson, Bruce
    Abbott, Kevin C.
    Bragg-Gresham, Jennifer
    Chen, Xiaoying
    Gipson, Debbie
    Gu, Haoyu
    Hirth, Richard A.
    Hutton, David
    Jin, Yan
    Kapke, Alissa
    Kurtz, Vivian
    Li, Yiting
    McCullough, Keith
    Modi, Zubin
    Morgenstern, Hal
    Mukhopadhyay, Purna
    Pearson, Jeffrey
    Pisoni, Ronald
    Repeck, Kaitlyn
    Schaubel, Douglas E.
    Shamraj, Ruth
    Steffick, Diane
    Turf, Megan
    Woodside, Kenneth J.
    Xiang, Jie
    Yin, Maggie
    Zhang, Xiaosong
    Shahinian, Vahakn
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (01) : SVI - SVII
  • [28] Red blood cell distribution width and mortality and hospitalizations in peritoneal dialysis patients
    Soohoo, Melissa
    Molnar, Miklos Z.
    Ujszaszi, Akos
    Obi, Yoshitsugu
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    Streja, Elani
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (12) : 2111 - 2118
  • [29] Dyslipidemia and Intraperitoneal Inflammation Axis in Peritoneal Dialysis Patients: A Cross-Sectional Pilot Study
    Stepanova, Natalia
    Driianska, Victoria
    Savchenko, Svitlana
    [J]. KIDNEY DISEASES, 2020, 6 (01) : 35 - 42
  • [30] Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma
    Valero, Cristina
    Pardo, Laura
    Sansa, Aina
    Garcia Lorenzo, Jacinto
    Lopez, Montserrat
    Quer, Miquel
    Leon, Xavier
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (02): : 336 - 343